title: Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction.
abstract: Although coronary stenting has been useful in the treatment of patients with suboptimal results, abrupt closure, and threatening occlusion after percutaneous transluminal coronary angioplasty (PTCA), its use in patients with acute myocardial infarction (AMI) is controversial because of the presence of intracoronary thrombus. In this study intracoronary stenting was used to treat suboptimal results and complications in 30 patients (35 lesions) undergoing PTCA during AMI. There were 28 men and 2 women, mean age 58 +/- 12 years. Thirteen patients (43%) had undergone rescue PTCA because of unsuccessful thrombolysis. Four patients had Killip's grade IV, 5 Killip's grade III, and 21 Killip's grade < or = 2 heart failure. Stents were placed in the 35 lesions because of suboptimal result (n = 19), early loss (n = 9), abrupt closure (n = 2), and coronary dissection with threatening occlusion (n = 5). All stents were deployed successfully. In-hospital complications included 1 in-hospital death (3.0%); no patient required emergency coronary artery bypass graft surgery. One patient (3.0%) developed abrupt closure and was successfully treated with PTCA and intracoronary thrombolysis. Vascular complications requiring blood transfusion developed in 3 of 30 patients (10%). At 11.8 months (range 4 to 24) follow-up, there were no deaths or myocardial infarction. One patient underwent coronary artery bypass grafting. The remaining patients were free of angina at follow-up. Thus, intracoronary stents can be used successfully to treat both suboptimal results and complications occurring in patients undergoing PTCA during AMI.
authors.affiliation: Cardiac Unit, Anchorena and Otamendi Hospitals, Buenos Aires, Argentina.
authors.forename: A E
authors.initials: AE
authors.lastname: Rodriguez
authors.forename: M
authors.initials: M
authors.lastname: Fernandez
authors.forename: O
authors.initials: O
authors.lastname: Santaera
authors.forename: M
authors.initials: M
authors.lastname: Larribau
authors.forename: V
authors.initials: V
authors.lastname: Bernardi
authors.forename: H
authors.initials: H
authors.lastname: Castaño
authors.forename: L F
authors.initials: LF
authors.lastname: Palacios
mesh_terms: D000328:Adult; D000368:Aged; D000784:Aortic Dissection / Q000628:therapy; D000787:Angina Pectoris / Q000517:prevention & control; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001803:Blood Transfusion; D003323:Coronary Aneurysm / Q000628:therapy; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000188:drug therapy / Q000628:therapy; D003331:Coronary Vessels; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D015607:Stents; D015996:Survival Rate; D015912:Thrombolytic Therapy; D017211:Treatment Failure; D014654:Vascular Patency